Myeongmun Pharmaceutical ranked among the top searched stocks for 3 days in the past month.


As of 11:30 AM on the 23rd, Myeongmun Pharmaceutical is trading at 8,850 KRW, down 6.74% from the previous day. This represents a 43.2% increase compared to November 25. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company focusing on prescription drugs.

Today, foreigners have a tentative net purchase of 340,079 shares of Myeongmun Pharmaceutical, and institutions have a net purchase of 29,000 shares. Over the past 5 days, individual investors have net purchased 167,291 shares, while foreigners and institutions have net sold 60,802 shares and 10,592 shares, respectively.


On December 22, Myeongmun Pharmaceutical was a market topic due to the news of sales of 'Camostat' for COVID-19 suppression, which led to an upward trend.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing